Carnitine Palmitoyl Transferase I and the Control of Myocardial Beta-oxidation Flux
Overview
Affiliations
Carnitine palmitoyltransferase I is assumed to be rate limiting for beta-oxidation in all tissues. However, the concentration of malonyl-CoA in heart and muscle is high and is enough to completely inhibit beta-oxidation if this assumption is correct. In this review, we consider whether: (i) there is a malonyl-CoA-insensitive carnitine palmitoyltransferase I activity; (ii) the measured malonyl-CoA concentration in the heart is physiologically meaningful; and (iii) carnitine palmitoyltransferase I is rate-limiting for beta-oxidation in the heart.
Deisl C, Moe O, Hilgemann D bioRxiv. 2024; .
PMID: 38293164 PMC: 10827192. DOI: 10.1101/2024.01.17.576124.
Morita H, Kano C, Ishii C, Kagata N, Ishikawa T, Hirayama A Sci Adv. 2023; 9(4):eadd2120.
PMID: 36696509 PMC: 9876546. DOI: 10.1126/sciadv.add2120.
Mota S, Pita I, Aguas R, Tagorti S, Virmani A, Pereira F Arch Toxicol. 2021; 95(8):2769-2784.
PMID: 34164711 DOI: 10.1007/s00204-021-03104-1.
Acylcarnitines: reflecting or inflicting insulin resistance?.
Schooneman M, Vaz F, Houten S, Soeters M Diabetes. 2012; 62(1):1-8.
PMID: 23258903 PMC: 3526046. DOI: 10.2337/db12-0466.
Sharma V, McNeill J World J Cardiol. 2011; 3(9):281-302.
PMID: 21949571 PMC: 3176897. DOI: 10.4330/wjc.v3.i9.281.